Barri Yousri M, Sanchez Edmund Q, Jennings Linda W, Melton Larry B, Hays Steven, Levy Marlon F, Klintmalm Goran B
Baylor Regional Transplant Institute, Dallas, TX 75246, USA.
Liver Transpl. 2009 May;15(5):475-83. doi: 10.1002/lt.21682.
The incidence of acute kidney injury (AKI) has been reported to vary between 17% and 95% post-orthotopic liver transplantation. This variability may be related to the absence of a uniform definition of AKI in this setting. The purpose of this study was to identify the degree of AKI that is associated with long-term adverse outcome. Furthermore, to determine the best definition (for use in future studies) of AKI not requiring dialysis in post-liver transplant patients, we retrospectively reviewed the effect of 3 definitions of AKI post-orthotopic liver transplantation on renal and patient outcome between 1997 and 2005. We compared patients with AKI to a control group without AKI by each definition. AKI was defined in 3 groups as an acute rise in serum creatinine, from the pretransplant baseline, of >0.5 mg/dL, >1.0 mg/dL, or >50% above baseline to a value above 2 mg/dL. In all groups, the glomerular filtration rate was significantly lower at both 1 and 2 years post-transplant. Patient survival was worse in all groups. Graft survival was worse in all groups. The incidence of AKI was highest in the group with a rise in creatinine of >0.5 mg/dL (78%) and lowest in patients with a rise in creatinine of >50% above 2.0 mg/dL (14%). Even mild AKI, defined as a rise in serum creatinine of >0.5 mg/dL, was associated with reduced patient and graft survival. However, in comparison with the other definitions, the definition of AKI with the greatest impact on patient's outcome post-liver transplant was a rise in serum creatinine of >50% above baseline to >2 mg/dL.
据报道,原位肝移植术后急性肾损伤(AKI)的发生率在17%至95%之间。这种变异性可能与该情况下AKI缺乏统一的定义有关。本研究的目的是确定与长期不良结局相关的AKI程度。此外,为了确定肝移植术后无需透析的AKI的最佳定义(用于未来研究),我们回顾性分析了1997年至2005年间原位肝移植术后AKI的3种定义对肾脏和患者结局的影响。我们根据每种定义将AKI患者与无AKI的对照组进行比较。AKI在3组中的定义为血清肌酐较移植前基线水平急性升高>0.5 mg/dL、>1.0 mg/dL或高于基线水平50%以上至>2 mg/dL。在所有组中,移植后1年和2年时肾小球滤过率均显著降低。所有组的患者生存率均较差。所有组的移植物生存率均较差。肌酐升高>0.5 mg/dL的组中AKI发生率最高(78%),肌酐升高超过2.0 mg/dL的50%的患者中AKI发生率最低(14%)。即使是定义为血清肌酐升高>0.5 mg/dL的轻度AKI也与患者和移植物生存率降低有关。然而,与其他定义相比,对肝移植术后患者结局影响最大的AKI定义是血清肌酐较基线水平升高50%以上至>2 mg/dL。